CA1008075A - Pharmacologically active new aminoalcohol esters and salts and a process for the preparation thereof - Google Patents

Pharmacologically active new aminoalcohol esters and salts and a process for the preparation thereof

Info

Publication number
CA1008075A
CA1008075A CA150,771A CA150771A CA1008075A CA 1008075 A CA1008075 A CA 1008075A CA 150771 A CA150771 A CA 150771A CA 1008075 A CA1008075 A CA 1008075A
Authority
CA
Canada
Prior art keywords
salts
preparation
pharmacologically active
active new
aminoalcohol esters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA150,771A
Other versions
CA150771S (en
Inventor
Karoly Felfoldi
Egon Karpati
Laszlo Szporny
Arpad Molnar
Mihaly Bartok
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richter Gedeon Vegyeszeti Gyar Nyrt
Original Assignee
Richter Gedeon Vegyeszeti Gyar RT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszeti Gyar RT filed Critical Richter Gedeon Vegyeszeti Gyar RT
Application granted granted Critical
Publication of CA1008075A publication Critical patent/CA1008075A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82—Xanthenes
    • C07D311/84—Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
CA150,771A 1971-09-03 1972-09-01 Pharmacologically active new aminoalcohol esters and salts and a process for the preparation thereof Expired CA1008075A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HURI444A HU163608B (en) 1971-09-03 1971-09-03

Publications (1)

Publication Number Publication Date
CA1008075A true CA1008075A (en) 1977-04-05

Family

ID=11000874

Family Applications (1)

Application Number Title Priority Date Filing Date
CA150,771A Expired CA1008075A (en) 1971-09-03 1972-09-01 Pharmacologically active new aminoalcohol esters and salts and a process for the preparation thereof

Country Status (18)

Country Link
AT (1) AT323741B (en)
AU (1) AU4622172A (en)
BE (1) BE788289A (en)
CA (1) CA1008075A (en)
CH (1) CH577957A5 (en)
CS (1) CS168004B2 (en)
DD (1) DD102142A5 (en)
DE (2) DE2265580C2 (en)
DK (1) DK144821C (en)
ES (1) ES406345A1 (en)
FI (1) FI56007C (en)
GB (1) GB1407456A (en)
HU (1) HU163608B (en)
IL (1) IL40169A (en)
NL (1) NL179205C (en)
PL (1) PL90702B1 (en)
SU (1) SU631068A3 (en)
YU (1) YU35762B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004045220A1 (en) * 2004-09-17 2006-04-06 Riemser Arzneimittel Ag New medicines

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1445551A1 (en) 1964-12-10 1969-05-22 Boheringer Mannheim Gmbh Process for the preparation of new, basic substituted xanthene-9-o1-9-carboxylic acid esters and their salts
US3523950A (en) * 1967-12-13 1970-08-11 Robins Co Inc A H Certain 4 - phenyl - 1,2,3,6 - tetrahydropyridyl-n-lower alkylene-ureas and derivatives

Also Published As

Publication number Publication date
HU163608B (en) 1973-09-27
DE2243143A1 (en) 1973-04-12
NL179205C (en) 1986-08-01
DE2243143C3 (en) 1982-01-21
SU631068A3 (en) 1978-10-30
DK144821C (en) 1982-11-01
ES406345A1 (en) 1976-01-16
DE2265580C2 (en) 1982-11-18
NL179205B (en) 1986-03-03
CH577957A5 (en) 1976-07-30
BE788289A (en) 1973-01-02
FI56007B (en) 1979-07-31
AU4622172A (en) 1974-03-07
NL7211966A (en) 1973-03-06
PL90702B1 (en) 1977-01-31
IL40169A0 (en) 1972-10-29
GB1407456A (en) 1975-09-24
DD102142A5 (en) 1973-12-05
DE2243143B2 (en) 1980-10-09
YU35762B (en) 1981-06-30
AT323741B (en) 1975-07-25
FI56007C (en) 1979-11-12
DK144821B (en) 1982-06-14
YU221172A (en) 1980-10-31
CS168004B2 (en) 1976-05-28
IL40169A (en) 1976-04-30

Similar Documents

Publication Publication Date Title
ZA722545B (en) New penicillin esters,salts thereof,and methods for their preparation
YU36738B (en) Process for obtaining pharmaceutically active alcaloid esters of the eburnamine type
AU461847B2 (en) Carbamoyl-triodophenoxyalkoxy-alkanoic acids, their salts and esters, the use thereof asx-ray contrast agents and process forthe production thereof
CA1008075A (en) Pharmacologically active new aminoalcohol esters and salts and a process for the preparation thereof
AU457864B2 (en) New cephalosporin esters, salts thereof and methods for their preparation
CA959843A (en) Process for the preparation of 1-phenyl-4-amino-cyclohex-2-ene-1-carboxylic-acid-esters and the salts thereof
CA1029017A (en) Pharmaceutically active new leurosine derivatives and a process for the preparation thereof
CA1023343A (en) Bis-piperazino-androstane derivatives and a process for the preparation thereof
CA985689A (en) Process for the preparation of basic esters and salts thereof
CA991203A (en) Phosphinylalkylaminobenzophenones and a process for their preparation
CA971182A (en) Bis-diene-(1,3)-iron monocarbonyls and a process for the production thereof
AU461481B2 (en) Pharmaceutically active new 1,3-amino-alcohol esters and their salts and a process for the preparation thereof
CA1003859A (en) Process for preparing a new thio-alkylamine and salts thereof
PH9295A (en) N-(substituted-penicilloyl)-amino carboxylic acids,their pharmaceutically acceptable salts and process for the preparation thereof
CA875555A (en) Therapeutically active esters and a method for their preparation
AU476553B2 (en) A process for the preparation of 3-mono-alkyl and 3, 6-dialkyl-resorcyclic esters
CA871734A (en) Pharmacologically active new substituted benzamides and process for preparing same
CA977340A (en) Process for preparing anthraquinone-1-acetic acid and the corresponding esters
CA866853A (en) 3,4,5-trimethoxy-benzamido alkanoic acids and their pharmaceutically acceptable salts
CA860321A (en) Process for preparing a new decapeptide and its salts
CA865781A (en) Phenoxyalkane-carboxylic acids, salts and esters thereof and process for their manufacture
CA990301A (en) Process for the production of pharmaceutically active 4-oxo-4h-1-benzopyrans
CA898279A (en) Hydroxy-hydroperoxides and a process for the preparation thereof
AU452479B2 (en) New oestrogenically highly active steroids and a process for their manufacture
AU448689B2 (en) O-phenylthionoethanephosphonic acid ester amides, a process for their preparation, and their use as insecticides, acarides and nematocides